Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26255,119,1.12 [0.91-1.37],0.2902161619710891
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",26989,200,0.95 [0.81-1.12],0.5316128608059635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26710,1319,1.10 [1.03-1.16],0.0036847657555626
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Candidiasis,27016,466,1.05 [0.94-1.16],0.3813597125358654
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26170,3457,1.06 [1.02-1.10],0.0040881008942911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26399,2852,1.06 [1.02-1.11],0.0052707860901155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,26734,1366,1.06 [1.00-1.13],0.0442606106897864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,26913,91,1.01 [0.80-1.28],0.9255637776597077
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25172,805,1.10 [1.02-1.19],0.0178966230450183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24355,947,1.10 [1.02-1.18],0.0097094651264036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24365,254,1.03 [0.89-1.19],0.6727240163252084
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18968,1663,1.08 [1.02-1.14],0.0067971312002622
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24149,369,1.10 [0.98-1.23],0.1225674290795696
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,26953,1585,1.03 [0.97-1.09],0.328590134654124
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Mycoses,27078,528,1.07 [0.97-1.18],0.1718518647115226
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26327,936,1.10 [1.02-1.18],0.0104235506789192
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27023,887,1.09 [1.01-1.17],0.0257123409502217
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25568,200,0.95 [0.81-1.12],0.5416964704335911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27138,47,1.01 [0.73-1.41],0.9463544513985844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other septicaemia,26915,779,1.09 [1.00-1.18],0.0445868124454458
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,26902,80,1.03 [0.80-1.33],0.8079337328062188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27040,190,1.08 [0.92-1.27],0.363557348674424
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27022,172,1.02 [0.86-1.21],0.8028339914041202
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25735,344,1.18 [1.05-1.33],0.0061867285550042
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,25650,259,1.02 [0.88-1.17],0.8037008176710703
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25494,126,1.06 [0.87-1.29],0.5592155410125718
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27113,34,0.90 [0.61-1.34],0.6064365862590306
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27065,153,0.99 [0.82-1.19],0.930620093000394
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Viral warts,26959,47,0.97 [0.70-1.36],0.8690274797829655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],26985,73,0.96 [0.74-1.26],0.7770053616014265
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm,26869,240,1.02 [0.88-1.18],0.752524749716081
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27034,70,1.10 [0.85-1.44],0.4681534148291419
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27033,70,1.15 [0.89-1.49],0.2955011855320009
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",26853,1207,1.01 [0.94-1.07],0.8718622528486852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of meninges,27110,78,1.25 [0.98-1.60],0.076230523853233
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27073,63,1.19 [0.90-1.56],0.2270334638138003
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27104,132,1.02 [0.84-1.24],0.8325745384451733
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm of ovary,27056,171,1.00 [0.84-1.19],0.9942564895217684
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27116,271,0.95 [0.83-1.09],0.4869810744524162
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Caecum,27122,248,0.94 [0.81-1.09],0.418732364753431
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27050,60,0.83 [0.62-1.13],0.2430908238578282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Descending colon,27121,154,0.84 [0.69-1.02],0.0720296331313627
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Rectum,27083,279,1.06 [0.92-1.21],0.42763566174734
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27033,491,0.93 [0.83-1.03],0.1555404026570587
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27118,295,0.92 [0.80-1.05],0.2131579325123539
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Carcinoma in situ of breast,22008,134,0.72 [0.58-0.89],0.0020125615747984
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22099,164,0.94 [0.78-1.12],0.4756223670170719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22075,32,0.62 [0.40-0.97],0.0367038240929641
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22110,67,1.14 [0.87-1.49],0.3530760513955174
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27071,135,0.93 [0.76-1.14],0.4933302949778858
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Haemangioma, any site",27072,134,0.93 [0.76-1.14],0.4759251487007991
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Leiomyoma of uterus,26159,574,0.97 [0.88-1.06],0.4682338718612304
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lung cancer and mesothelioma,19472,310,1.05 [0.94-1.19],0.3871657845008991
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Lymphoid leukaemia,22081,38,0.83 [0.56-1.22],0.343772321724035
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22219,176,0.98 [0.83-1.16],0.8183063992051574
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22152,109,0.97 [0.78-1.21],0.7749610628168851
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22228,185,0.94 [0.79-1.12],0.4935346874666533
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22112,69,1.19 [0.91-1.55],0.2017442399314049
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22113,70,1.17 [0.90-1.52],0.2509752428804555
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22096,53,0.97 [0.71-1.33],0.8496292404112324
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22182,139,1.02 [0.84-1.23],0.8566411220529153
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22145,102,1.13 [0.91-1.41],0.2758194407019777
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22121,78,1.05 [0.81-1.35],0.7195354120119154
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22085,42,1.26 [0.90-1.75],0.1720652882898268
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22124,81,1.02 [0.80-1.32],0.8612912143087728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi,26882,227,1.08 [0.93-1.25],0.3166208667791771
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanocytic naevi of trunk,27093,78,1.05 [0.82-1.36],0.6865251695401234
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Melanoma in situ,22078,88,1.10 [0.87-1.40],0.4312635459264845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22122,79,1.03 [0.80-1.33],0.811056453651646
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22194,151,1.11 [0.93-1.33],0.2426450771477943
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22272,229,0.99 [0.86-1.14],0.8835103870504779
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22135,92,1.37 [1.10-1.70],0.0056272804682103
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,Other benign neoplasms of skin,26913,163,0.90 [0.75-1.08],0.2582734014574086
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",22966,923,0.98 [0.91-1.06],0.6348092925578082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23005,962,0.98 [0.91-1.06],0.6666461903604645
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26834,362,1.03 [0.92-1.16],0.5938499750990383
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25145,105,1.08 [0.87-1.35],0.4884304343216672
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26541,69,1.26 [0.98-1.63],0.0764510068346858
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26135,2935,1.06 [1.02-1.11],0.0037709954692579
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,25510,36,0.79 [0.53-1.18],0.2444553339728818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,26739,48,1.39 [1.03-1.88],0.0326569616878691
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26557,1517,1.07 [1.01-1.13],0.0269100510700999
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26557,1517,1.07 [1.01-1.13],0.0269100510700999
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25108,68,0.97 [0.73-1.28],0.8366289081180146
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26733,1259,1.14 [1.07-1.21],4.367711207026685e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,26812,121,0.86 [0.70-1.07],0.1838333222126167
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,26523,51,1.03 [0.75-1.42],0.8369309027488445
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,26529,57,0.94 [0.70-1.28],0.696928509624649
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,26922,231,0.96 [0.83-1.12],0.6043932508295528
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27023,60,1.20 [0.91-1.59],0.2068192694484854
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",26884,193,0.77 [0.65-0.92],0.0035590666962821
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,25605,131,1.07 [0.88-1.30],0.4825097150050639
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21810,248,1.05 [0.91-1.21],0.5394246106214107
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25721,67,0.88 [0.66-1.17],0.3725320550176408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25718,64,1.25 [0.95-1.64],0.1081636690752538
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,21615,53,1.34 [1.01-1.79],0.045581917806026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,24882,69,1.14 [0.87-1.48],0.3458099184457246
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,24535,247,1.07 [0.93-1.23],0.375894410942625
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",26699,510,1.01 [0.92-1.12],0.7794213940635127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,26475,286,0.96 [0.84-1.10],0.5522941569280384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26275,86,1.22 [0.96-1.54],0.1005698874200569
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,26741,1928,1.05 [1.00-1.11],0.0454626875818005
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,23994,1878,1.07 [1.01-1.12],0.0165136418147783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",21621,59,1.18 [0.89-1.57],0.2626988904480206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24066,118,1.03 [0.84-1.27],0.7718630380986369
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21844,282,1.02 [0.89-1.17],0.7555693797828529
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21610,48,1.40 [1.03-1.89],0.0313213986593728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24692,3130,1.08 [1.04-1.12],0.0002503382447212
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21759,197,1.01 [0.86-1.19],0.924809415282798
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22096,534,1.06 [0.96-1.16],0.2698737797307775
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27033,361,1.12 [0.99-1.26],0.0609659312650177
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,26849,177,1.09 [0.93-1.29],0.2923195736348021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21664,102,0.91 [0.72-1.15],0.432546173683588
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",21617,55,1.10 [0.81-1.48],0.5424896884462332
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26256,2308,1.03 [0.99-1.08],0.1812677939627131
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21767,205,1.06 [0.90-1.24],0.4853623939764663
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21774,212,1.17 [1.01-1.36],0.0407561907459268
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22092,530,1.13 [1.02-1.24],0.0168253966466635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21654,92,1.05 [0.83-1.33],0.6977966904290682
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,26839,167,1.06 [0.89-1.26],0.5400881593467867
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22189,627,1.01 [0.93-1.11],0.758574401718566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22126,564,1.07 [0.97-1.17],0.1724706585422666
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24358,70,1.32 [1.02-1.70],0.0343193620005155
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26236,4674,1.08 [1.05-1.12],4.011825753954672e-06
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24025,77,1.02 [0.79-1.32],0.8763397718246116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24037,89,1.02 [0.80-1.29],0.8854154188098164
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,26943,2067,0.99 [0.94-1.04],0.7736709052539082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",26947,2065,0.99 [0.94-1.04],0.7757161155993338
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24029,81,1.09 [0.85-1.40],0.5058380838429513
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,26731,1569,1.06 [1.00-1.13],0.0330640353105747
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23079,1517,1.06 [1.00-1.12],0.0686720273330963
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27123,180,1.08 [0.92-1.28],0.3579367533916081
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26244,55,1.23 [0.92-1.64],0.1700284588662095
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25289,127,1.01 [0.83-1.24],0.9111800119439504
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25356,194,1.19 [1.02-1.39],0.0300659994455393
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21824,262,1.26 [1.10-1.44],0.0007687670535482
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25326,138,1.02 [0.84-1.23],0.8745377832937812
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1682,45,1.00 [0.71-1.41],0.9933867388660572
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1798,185,1.12 [0.95-1.32],0.1931780243806938
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25213,25,1.44 [0.93-2.22],0.1003001978765854
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1668,32,0.97 [0.64-1.45],0.8730258555188842
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26655,1467,1.11 [1.04-1.17],0.0006667660445175
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,26529,340,0.93 [0.82-1.05],0.2350389909917725
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,24763,475,1.05 [0.95-1.17],0.3085476126054715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22288,726,1.09 [1.00-1.18],0.0501401543970165
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27036,232,0.90 [0.77-1.05],0.1745411282044648
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26147,51,1.16 [0.86-1.57],0.3196788458570542
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Angina pectoris,25609,865,1.15 [1.07-1.24],0.0002504279381906
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26191,95,0.94 [0.74-1.19],0.5953674267524303
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26129,33,1.46 [1.02-2.07],0.0369007688225169
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26244,148,1.11 [0.93-1.33],0.2408638524236925
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17629,1458,1.03 [0.97-1.10],0.3015037225132313
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,AV-block,23757,234,1.02 [0.88-1.19],0.748100836210815
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27096,303,0.89 [0.78-1.02],0.0945046504611693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiac arrest,16299,128,1.32 [1.09-1.60],0.0050915535834661
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23657,134,0.90 [0.74-1.11],0.3262062476500575
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",23602,79,1.01 [0.78-1.30],0.9534182883635792
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27133,34,1.08 [0.74-1.58],0.6850420881494909
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Conduction disorders,24242,719,1.02 [0.93-1.11],0.6926179745360812
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26231,1497,1.11 [1.05-1.17],0.0004430695967074
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24376,7174,1.04 [1.02-1.07],0.0013762238753304
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25631,247,0.97 [0.84-1.12],0.6754321540077548
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Endocarditis,23585,62,1.12 [0.84-1.48],0.4386065424100674
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27038,848,1.08 [1.00-1.17],0.0398026463504167
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertension,24997,6078,1.05 [1.02-1.08],0.0023866033073244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25009,6090,1.05 [1.02-1.08],0.0026912959382954
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27025,42,0.70 [0.48-1.02],0.0628973442443951
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19083,164,1.08 [0.90-1.29],0.4022017528198061
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19021,102,1.31 [1.06-1.63],0.0138300470391157
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Hypotension,26997,1094,1.01 [0.94-1.08],0.7301934158155693
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26384,97,1.14 [0.91-1.43],0.2434591121335025
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26418,1674,1.12 [1.06-1.18],3.5055974586969086e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26824,453,1.05 [0.95-1.17],0.341822695878347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Left bundle-branch block,23819,296,1.06 [0.93-1.21],0.3873233287434673
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,26915,600,1.07 [0.98-1.17],0.1439885215826068
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25230,486,1.10 [0.99-1.21],0.0685918865649618
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27113,85,1.32 [1.05-1.66],0.0164205310510818
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27132,242,1.03 [0.89-1.19],0.7117581666089017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Oesophageal varices,25421,37,0.80 [0.54-1.19],0.2654578093920104
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other aneurysm,26151,55,0.78 [0.57-1.08],0.1420739359254379
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arrhythmias,23880,357,1.07 [0.95-1.21],0.2393518421225123
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26159,63,1.32 [1.01-1.72],0.0383831421002284
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26285,189,0.97 [0.82-1.14],0.6789579100363214
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,23682,159,0.98 [0.82-1.18],0.8302498173899443
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other disorders of veins,25479,95,0.96 [0.75-1.21],0.7040156897003866
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25428,44,1.24 [0.89-1.71],0.2005428981012085
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,25887,38,0.82 [0.56-1.21],0.3245579005807066
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,25542,158,1.03 [0.86-1.24],0.7395803035391912
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24320,797,0.99 [0.91-1.07],0.8057361443233164
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,25946,43,0.72 [0.49-1.04],0.0799194175220474
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26586,490,1.02 [0.92-1.13],0.7250962047946357
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26570,322,1.04 [0.91-1.17],0.5898863296548282
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26393,544,0.96 [0.87-1.06],0.4204723085196752
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16460,289,1.07 [0.94-1.23],0.3051370894542676
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26350,267,1.06 [0.92-1.21],0.4326298168847384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25708,324,1.02 [0.90-1.15],0.798027147347975
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26682,434,1.01 [0.90-1.12],0.9162213785246875
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27062,591,1.00 [0.91-1.10],0.934194270894792
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Right bundle-branch block,23744,221,0.99 [0.85-1.15],0.8866504324943811
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26563,315,1.04 [0.92-1.18],0.5428379137949637
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26010,161,0.96 [0.80-1.15],0.6247788467692381
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26817,530,1.06 [0.96-1.17],0.2198439365574422
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26791,576,1.04 [0.95-1.15],0.3609464411457908
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26351,70,1.00 [0.76-1.31],0.9973665094451448
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26142,46,0.82 [0.58-1.17],0.2758652129703449
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26588,217,1.04 [0.89-1.21],0.6365555877261615
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26512,197,1.13 [0.96-1.32],0.1426038342548088
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Varicose veins,25842,458,1.00 [0.90-1.11],0.9502534058889888
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26107,97,0.93 [0.74-1.18],0.5467605057913048
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter IX Diseases of the circulatory system,Venous thromboembolism,26924,691,1.01 [0.92-1.10],0.8813847892166612
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27093,215,1.02 [0.87-1.19],0.8265381226377975
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24081,1831,1.07 [1.01-1.13],0.0142717226145922
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Any mental disorder,26525,4275,1.04 [1.01-1.08],0.0127739843758147
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27061,254,0.98 [0.85-1.13],0.8051719452525031
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24199,1949,1.07 [1.02-1.13],0.0088793253276379
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22344,94,1.05 [0.83-1.33],0.6654280732485919
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Smoking dependency,26728,1188,1.06 [0.99-1.13],0.0752872074343514
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23618,1368,1.05 [0.98-1.11],0.1489892242385004
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter V Mental and behavioural disorders,Vascular dementia,26634,100,0.88 [0.69-1.11],0.2774380721216132
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Alzheimer disease,27137,356,0.96 [0.85-1.08],0.4801621889011841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",18500,58,0.97 [0.72-1.31],0.8622568103178501
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Bell's palsy,24997,85,1.00 [0.78-1.28],0.9817962056027624
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25530,618,0.99 [0.90-1.08],0.7528686465726357
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral cysts,26740,220,0.99 [0.85-1.16],0.9021198928671909
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27064,274,1.00 [0.87-1.15],0.9894119180412746
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,26654,39,0.92 [0.63-1.33],0.6604070458338469
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27123,45,1.52 [1.12-2.07],0.0076502636804911
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",26573,53,0.83 [0.60-1.16],0.2729816475672379
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Epilepsy,25662,281,1.03 [0.90-1.18],0.6902667735379016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26720,1339,1.05 [0.99-1.11],0.138667063791292
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27089,508,1.05 [0.95-1.16],0.321155275099389
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26506,2883,1.00 [0.96-1.05],0.9088009850666258
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Generalized epilepsy,26767,46,1.19 [0.86-1.64],0.2874439105076726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hemiplegia,27008,218,1.07 [0.92-1.25],0.3708672147766213
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Hydrocephalus,26587,67,1.12 [0.86-1.47],0.4070901945082592
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27118,75,1.12 [0.87-1.45],0.3650137888437539
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25034,122,0.92 [0.75-1.14],0.4510496799422312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,24976,64,1.09 [0.82-1.44],0.557504954789221
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Memory loss,26510,96,1.01 [0.80-1.27],0.9531428732120456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Migraine,25885,504,1.06 [0.96-1.17],0.2845070678517093
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27022,453,1.04 [0.94-1.16],0.4397181114899051
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Motor neuron disease,18586,119,1.02 [0.82-1.26],0.8730846720736778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,26923,142,1.11 [0.92-1.34],0.2679834191866729
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26289,1377,1.01 [0.95-1.08],0.6390708526345606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Neurological diseases,25533,3770,1.03 [0.99-1.06],0.1805489859122016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,26774,159,1.09 [0.92-1.30],0.3290127011060446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25335,423,1.08 [0.97-1.20],0.174504712024934
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27081,230,1.13 [0.97-1.30],0.1130109344981013
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21839,660,1.03 [0.95-1.13],0.4693160844713088
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,26589,69,1.06 [0.81-1.38],0.6957713575287933
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other disorders of nervous system,26642,122,0.87 [0.70-1.07],0.1903204441823371
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,26765,184,1.08 [0.91-1.27],0.3813240279985397
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25007,95,0.98 [0.78-1.24],0.8910204045119904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other headache syndromes,25454,73,1.29 [1.00-1.65],0.0488635101463713
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other neurological diseases,27020,500,1.02 [0.93-1.13],0.6409068524008477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Other sleep disorders,25783,402,1.01 [0.90-1.13],0.9175980358023744
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Parkinson's disease,27113,306,1.01 [0.89-1.15],0.8782193227786017
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,26603,83,1.12 [0.87-1.43],0.3762424632121991
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Restless leg syndrome,27136,103,1.01 [0.81-1.27],0.918124020468392
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Sleep apnoea,26959,318,1.01 [0.88-1.14],0.929568462215008
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Small fibre neuropathy,26891,40,1.36 [0.97-1.89],0.0729748916613594
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27127,147,0.95 [0.79-1.15],0.6289067801879322
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,24977,65,0.79 [0.59-1.06],0.1178447779780603
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27137,360,0.96 [0.85-1.08],0.5103892022557146
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),26591,97,0.87 [0.69-1.11],0.2709854996731892
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,26559,109,0.89 [0.72-1.12],0.3305324747113255
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,26680,479,1.05 [0.95-1.17],0.3303820531383635
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,26992,172,1.09 [0.92-1.30],0.30303300377899
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26033,61,0.94 [0.69-1.26],0.6584882661694191
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26026,54,1.12 [0.82-1.51],0.4794232582362207
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27020,54,1.43 [1.08-1.90],0.0125740229039113
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,26851,164,1.08 [0.90-1.28],0.4120544831541184
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1675,38,1.06 [0.73-1.53],0.7714566264739904
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2016,68,0.95 [0.72-1.26],0.7361530782003509
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,26538,88,0.94 [0.74-1.20],0.6272653523274773
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,26960,1056,1.08 [1.01-1.16],0.0274252000873816
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26718,746,1.01 [0.93-1.10],0.841665396897445
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26265,293,1.08 [0.95-1.23],0.2578435462718401
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27044,843,1.06 [0.98-1.14],0.1760714169536762
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27120,68,1.10 [0.84-1.44],0.5013642747393112
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,26968,767,1.07 [0.98-1.16],0.1276918202532839
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27092,405,1.03 [0.92-1.16],0.5822830337643652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27043,200,0.98 [0.83-1.15],0.7973360503622166
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26012,40,0.91 [0.63-1.32],0.6256725314771774
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26019,47,1.22 [0.89-1.67],0.2221159732627571
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26037,65,1.08 [0.82-1.43],0.5836066007093172
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27049,714,1.00 [0.92-1.09],0.977182247152948
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,26516,181,0.99 [0.83-1.17],0.8867175371646436
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26266,65,1.13 [0.86-1.49],0.3924534175723917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,26789,102,1.00 [0.80-1.26],0.982299553572715
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,26996,309,1.05 [0.92-1.19],0.4445697066279048
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26410,209,1.06 [0.91-1.24],0.4810092933127997
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,26974,131,0.93 [0.76-1.14],0.4713593391087446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26803,468,1.03 [0.92-1.14],0.6212210124805104
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,26601,151,0.95 [0.79-1.15],0.5861466551010353
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25347,2470,1.05 [1.01-1.10],0.0269402059508505
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,26956,269,1.05 [0.92-1.20],0.4870681354667054
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27111,153,1.04 [0.87-1.25],0.6502726254892466
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26356,384,0.98 [0.87-1.10],0.7091171545315225
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,26750,63,0.88 [0.65-1.18],0.3817887960897869
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27105,53,1.16 [0.85-1.57],0.3479001231011945
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26065,93,0.94 [0.74-1.19],0.5884227716723913
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26121,149,0.93 [0.77-1.13],0.4857400035468803
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26010,106,1.28 [1.04-1.57],0.0219530834319826
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26272,71,1.09 [0.83-1.42],0.5403512686056935
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",25961,57,0.79 [0.57-1.08],0.1408457433786361
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,26452,117,0.94 [0.76-1.16],0.5508301883037531
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",26515,180,0.96 [0.81-1.14],0.610497920043137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26103,131,1.07 [0.87-1.30],0.5301707196793168
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26002,98,1.18 [0.95-1.47],0.1414928528524766
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,25979,75,1.28 [1.00-1.65],0.0486050952498014
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,24958,2081,1.03 [0.98-1.08],0.3069132468305751
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26055,83,1.06 [0.83-1.36],0.634391416505193
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,26873,423,0.99 [0.89-1.10],0.8438669585697272
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,26496,46,1.05 [0.76-1.47],0.7573144298511412
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),26616,166,1.09 [0.92-1.30],0.3284955341287085
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,26898,113,0.99 [0.80-1.23],0.9487775810901276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27089,116,0.91 [0.74-1.13],0.4109840364119248
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27011,139,1.12 [0.93-1.35],0.2366616558134797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,26850,65,1.11 [0.84-1.46],0.4542802900106435
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,26851,66,0.88 [0.66-1.18],0.3921193716595865
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27033,813,1.03 [0.95-1.11],0.5226491767697836
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,26779,559,1.07 [0.97-1.17],0.1731868594528731
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26343,123,0.97 [0.79-1.19],0.7672057304045895
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26306,86,1.00 [0.78-1.28],0.9905407065538536
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute pharyngitis,26870,83,0.84 [0.65-1.09],0.2009979446647864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27014,227,0.85 [0.72-0.99],0.0383469283364159
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,26851,64,0.85 [0.64-1.15],0.2947104711727706
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza,25436,126,0.89 [0.72-1.09],0.2634050320690336
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25434,124,0.91 [0.73-1.12],0.351563832474719
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19286,124,1.14 [0.93-1.39],0.2067927883230347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Allergic rhinitis,26987,283,1.12 [0.99-1.28],0.0810138976780331
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",20999,2023,1.05 [1.00-1.11],0.0415327680074102
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21159,1997,1.05 [1.00-1.11],0.0386757293867545
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),26724,120,1.04 [0.85-1.27],0.7191386174713599
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25375,65,1.17 [0.89-1.53],0.2589075979908645
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Bronchiectasis,23494,410,1.13 [1.01-1.26],0.0302315623654707
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23154,70,1.05 [0.80-1.37],0.7458870173865207
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26000,2916,1.06 [1.01-1.10],0.0078604943120758
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",25863,62,0.72 [0.53-0.99],0.0416587439011821
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Chronic sinusitis,25944,143,1.12 [0.93-1.34],0.2502982844114002
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",26967,1049,1.07 [1.00-1.14],0.0668693964285515
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Deviated nasal septum,25875,74,1.14 [0.88-1.48],0.316461937715395
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25077,5100,1.07 [1.03-1.10],6.56781682441227e-05
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26134,333,1.09 [0.97-1.23],0.1532328735455649
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Early onset COPD,26230,312,1.03 [0.91-1.18],0.6073491248796219
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Emphysema,23353,269,1.27 [1.13-1.44],0.0001167247925725
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25536,227,1.08 [0.94-1.26],0.2796480149793616
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Influenza and pneumonia,26944,1634,1.06 [1.00-1.12],0.0444965947776489
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Interstitial lung disease,25573,264,1.06 [0.92-1.21],0.4321141053010803
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Later onset COPD,26240,737,1.08 [1.00-1.17],0.0563705573120348
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27130,222,0.98 [0.84-1.15],0.8311645539780863
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Nasal polyp,25866,65,0.90 [0.68-1.21],0.4930607528238999
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,26916,908,1.05 [0.97-1.13],0.2356601046929481
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of pleura,26950,1731,1.06 [1.01-1.12],0.028266993128501
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26582,781,1.12 [1.04-1.21],0.0048059989531751
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other pleural conditions,25255,36,0.81 [0.54-1.20],0.2891527653194407
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27058,337,1.04 [0.92-1.17],0.5813597643012218
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27050,1169,1.08 [1.01-1.15],0.0225630829122408
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural effusion,26058,839,1.06 [0.98-1.15],0.1404800376729451
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pleural plaque,25263,44,1.07 [0.76-1.50],0.6894817675439964
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26717,1407,1.07 [1.01-1.14],0.0203146851142841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27103,195,0.97 [0.82-1.14],0.676896423944203
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pneumothorax,25307,88,1.09 [0.86-1.38],0.473451467776888
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pollen allergy,27106,237,1.14 [0.99-1.32],0.0744083222096545
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Pulmonary oedema,26782,61,1.01 [0.75-1.35],0.9643219639586116
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19214,52,1.28 [0.97-1.69],0.0756117950535176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,26892,884,1.04 [0.96-1.12],0.3196082982079686
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26084,283,1.13 [0.99-1.29],0.0741656614850188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Viral pneumonia,25516,206,0.98 [0.84-1.15],0.8431246255168363
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",26735,164,0.98 [0.82-1.18],0.8537675568312244
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13112,106,1.12 [0.91-1.40],0.2886117285988316
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19335,37,1.03 [0.71-1.50],0.8762536763358864
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute appendicitis,26951,146,0.89 [0.74-1.08],0.2474222372494767
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute gastritis,20372,91,1.00 [0.79-1.26],0.9797042442412852
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute pancreatitis,24856,160,1.20 [1.01-1.43],0.0388101961385996
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Acute peritonitis,26572,87,1.13 [0.89-1.43],0.3094768586523261
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26264,33,0.86 [0.57-1.29],0.4622653387709855
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Barrett oesophagus,20611,330,1.02 [0.90-1.16],0.7637526033918276
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",24774,78,1.18 [0.92-1.52],0.1875023117742323
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",26711,78,1.18 [0.92-1.51],0.1943891826530503
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholecystitis,24878,182,1.12 [0.95-1.32],0.1726710746671475
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Cholelithiasis,25870,1174,1.03 [0.97-1.10],0.359112680784829
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic gastritis,20618,337,1.13 [1.00-1.28],0.044290241170845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Chronic pancreatitis,24736,40,1.06 [0.74-1.51],0.7503392383992702
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27054,71,0.84 [0.63-1.11],0.2105243626624923
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Coeliac disease,25607,149,1.00 [0.83-1.20],0.9861960187878696
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Collagenous colitis,25251,111,0.93 [0.75-1.16],0.5235868445385685
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,26999,149,1.05 [0.88-1.27],0.5820620110371341
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Constipation,26795,1714,1.01 [0.95-1.06],0.8313966047682456
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn disease,25234,94,1.08 [0.86-1.36],0.509581511749529
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26781,70,1.02 [0.78-1.34],0.8836579325134782
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25237,97,1.05 [0.83-1.32],0.6832295600937583
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Dental caries,26332,228,1.08 [0.93-1.25],0.3347458722738451
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25530,2449,1.03 [0.98-1.08],0.1972651047551953
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of appendix,26994,189,0.97 [0.83-1.15],0.7579783403580876
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of liver,27035,804,1.07 [0.99-1.16],0.0955916585181062
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24855,4574,1.01 [0.98-1.05],0.4814981276660885
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26677,573,1.07 [0.97-1.17],0.175985701110569
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27013,528,1.08 [0.98-1.19],0.1421361510147639
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26217,113,1.01 [0.81-1.25],0.937570668419969
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26069,65,1.12 [0.85-1.48],0.4101244162393597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26841,1383,0.97 [0.91-1.03],0.3338793249046863
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diseases of tongue,26078,110,0.80 [0.64-1.00],0.0546065315432029
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26276,1580,1.08 [1.02-1.15],0.0057032429580537
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22475,3177,1.03 [0.99-1.08],0.1017768958067059
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Duodenal ulcer,20408,127,1.07 [0.88-1.31],0.4928916386632148
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27084,107,1.05 [0.84-1.31],0.675071334969127
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27034,60,1.21 [0.91-1.60],0.1813051989724799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26323,92,1.00 [0.79-1.27],0.9863260952549796
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19409,111,1.12 [0.91-1.39],0.2748040089692863
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Functional dyspepsia,20936,655,1.09 [0.99-1.18],0.0658636554427771
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastric ulcer,20626,345,0.97 [0.86-1.10],0.6695947931013457
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23046,2765,1.02 [0.98-1.06],0.3728000632482795
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20747,466,1.00 [0.90-1.11],0.9879709521794484
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21214,8369,1.03 [1.01-1.06],0.0137544855957259
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,GI-bleeding,26585,1127,0.98 [0.91-1.04],0.4699257916689083
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26167,63,0.93 [0.69-1.24],0.6033214874817119
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20263,1255,1.07 [1.01-1.14],0.0325874101392215
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26272,41,0.91 [0.63-1.30],0.5961326447449534
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Hernia,25958,2877,1.01 [0.97-1.06],0.5700152532041307
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impacted teeth,27044,55,1.34 [1.01-1.79],0.0424453980588008
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Impaction of intestines,19362,64,1.37 [1.05-1.79],0.0194800102170399
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Inguinal hernia,23243,162,0.78 [0.65-0.95],0.0115878598484199
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19399,101,1.05 [0.84-1.31],0.6723127129325511
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25629,171,1.00 [0.84-1.19],0.9852918753641214
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20104,806,1.06 [0.98-1.15],0.1259966653389724
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27121,355,1.18 [1.05-1.32],0.0063641093301814
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,25952,812,1.06 [0.98-1.15],0.1370649949708837
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26236,1096,1.06 [0.99-1.13],0.0980556021379736
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20438,157,1.06 [0.88-1.27],0.5271052010495783
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oesophagitis,20850,569,1.01 [0.92-1.11],0.8505934518575355
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27090,154,1.09 [0.91-1.31],0.3243463608962312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23140,59,1.09 [0.82-1.47],0.5468489008673845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20563,1265,1.06 [1.00-1.13],0.0562969664515705
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,24995,299,1.17 [1.03-1.32],0.0181868848195221
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,24888,192,1.08 [0.92-1.26],0.3766804316217161
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestine,20879,1581,1.01 [0.95-1.06],0.8562437483642279
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of intestines,24982,5684,1.02 [0.99-1.05],0.1922323699771326
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26070,228,1.07 [0.93-1.25],0.3501033635089319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of liver,26907,676,1.07 [0.99-1.17],0.1040492683221762
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20849,568,1.02 [0.93-1.12],0.6538427016902663
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of pancreas,24853,157,1.11 [0.93-1.33],0.2405581895221822
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,26949,464,1.05 [0.95-1.17],0.3645923102164778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21351,1070,0.97 [0.91-1.04],0.4189316240110845
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26601,1143,0.97 [0.91-1.04],0.451520580390041
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26290,186,1.04 [0.88-1.23],0.6109926343225758
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21065,1767,1.01 [0.96-1.07],0.5938634996226855
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22387,2106,1.00 [0.95-1.05],0.8892413927834593
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26328,97,0.88 [0.69-1.12],0.2937162108659188
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26105,965,1.05 [0.97-1.12],0.2319962804111351
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19624,326,1.08 [0.95-1.22],0.2178019171316831
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27023,68,1.19 [0.92-1.56],0.1862183665258952
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19787,489,1.05 [0.94-1.16],0.3948408991648611
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25585,127,0.96 [0.78-1.18],0.7139033767591065
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27128,68,0.87 [0.66-1.16],0.3450178862601037
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26104,124,0.95 [0.77-1.17],0.6287497484346092
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Toxic colitis,25206,66,1.00 [0.76-1.32],0.9943605202220728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20514,233,1.13 [0.97-1.30],0.1103859395009477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ulcerative colitis,25304,164,1.20 [1.01-1.42],0.0386714199367943
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25275,135,1.25 [1.04-1.50],0.017775237711758
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Umbilical hernia,23252,171,0.84 [0.70-1.01],0.058143518055558
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19489,191,1.02 [0.87-1.20],0.8047641606923982
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Ventral hernia,23329,248,1.03 [0.89-1.19],0.7133764819381248
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XI Diseases of the digestive system,Volvulus,19383,85,0.92 [0.72-1.18],0.5214065442770449
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27051,258,1.05 [0.91-1.21],0.5050657594661327
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,26820,74,1.01 [0.78-1.32],0.9310260807153355
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25087,219,1.06 [0.91-1.23],0.466502245501319
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26613,622,1.07 [0.98-1.17],0.1316521394450838
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26132,141,1.12 [0.93-1.34],0.2506445061877266
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25196,328,0.95 [0.84-1.08],0.4272901477159773
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,26825,277,1.12 [0.98-1.28],0.0953121632780771
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27027,479,1.02 [0.92-1.14],0.6538358545962162
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,26599,51,0.93 [0.67-1.28],0.6502607443307566
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25544,3142,1.02 [0.98-1.07],0.2335693703370998
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26685,472,0.94 [0.85-1.05],0.2694192151593182
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26542,329,0.93 [0.81-1.05],0.2353898140937866
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26825,834,1.07 [0.99-1.16],0.0862497025733699
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27115,75,0.95 [0.73-1.24],0.7083833507904869
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,24958,90,0.80 [0.62-1.03],0.0794250267334544
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26258,45,1.14 [0.82-1.58],0.4354061423969974
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,26810,262,1.11 [0.96-1.27],0.153211356492176
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25282,414,1.01 [0.91-1.13],0.8249758131407378
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,24914,46,0.93 [0.66-1.31],0.6913977536913236
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27032,83,0.81 [0.63-1.06],0.1224636809327107
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26148,157,1.15 [0.97-1.38],0.1143408766581841
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,26910,164,0.81 [0.67-0.97],0.0225569433952404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,26602,54,0.97 [0.71-1.33],0.8412551205244942
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,24931,63,1.10 [0.83-1.46],0.4937958183265897
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26448,1580,1.03 [0.97-1.09],0.3857914774929843
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25316,448,1.04 [0.94-1.16],0.4417267959982919
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,24918,50,0.97 [0.70-1.34],0.8647872322109913
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27051,305,0.90 [0.79-1.03],0.1139749634453606
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,26630,82,0.90 [0.69-1.16],0.4162283070835877
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,26980,234,0.89 [0.76-1.03],0.118968412232874
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27087,294,1.01 [0.89-1.16],0.8539012118465765
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25028,160,1.12 [0.94-1.33],0.2102593147864286
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25128,260,0.99 [0.86-1.14],0.8618325054486312
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27073,280,1.01 [0.88-1.16],0.9098605418638704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25064,196,1.07 [0.91-1.25],0.4276540273276636
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27100,151,0.93 [0.77-1.12],0.4346595077514728
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23152,127,1.17 [0.96-1.43],0.1129020532563029
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,24662,6332,1.01 [0.99-1.04],0.3377716769446137
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23274,4944,1.03 [0.99-1.06],0.1110404585259275
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23100,75,1.05 [0.81-1.36],0.7307445726521333
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23270,152,1.09 [0.91-1.30],0.3765569583641077
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23326,208,1.07 [0.92-1.25],0.3937340172274581
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,26848,113,0.95 [0.76-1.18],0.6311667706749609
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23232,114,0.89 [0.71-1.11],0.2859303404664267
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19693,1363,1.03 [0.97-1.10],0.313003583370553
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",26985,220,1.01 [0.87-1.18],0.8514677000337261
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23725,607,1.04 [0.95-1.15],0.3509143026157499
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22820,8037,1.01 [0.98-1.04],0.476229358612857
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24310,137,0.99 [0.82-1.21],0.9493221181684592
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23156,131,1.21 [1.00-1.46],0.0507297270587517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23709,684,1.02 [0.94-1.12],0.5872313666662365
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26125,3007,1.05 [1.01-1.09],0.0226428085823765
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23198,173,0.98 [0.82-1.17],0.8239336722938779
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23396,371,1.14 [1.01-1.28],0.0275720610043274
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23192,167,1.12 [0.94-1.33],0.205945385708539
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26207,102,0.83 [0.66-1.05],0.1279739915765552
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20189,1859,1.04 [0.99-1.10],0.1073268715406092
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18552,222,1.14 [0.98-1.33],0.0842951867267013
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27125,219,1.11 [0.96-1.30],0.1652393701515688
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18427,97,1.22 [0.98-1.52],0.0780152076486712
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18904,574,0.93 [0.84-1.02],0.1262555939760467
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23358,333,1.02 [0.90-1.15],0.7919135912854446
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,18956,626,0.98 [0.90-1.08],0.6961391447250986
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23186,68,1.14 [0.87-1.50],0.3445730964449763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23825,707,1.07 [0.98-1.16],0.1183428632999973
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23453,335,1.14 [1.01-1.28],0.0385010733739036
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,18914,584,1.00 [0.91-1.10],0.94503721637455
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23115,90,1.35 [1.08-1.69],0.0086690589111139
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23094,69,1.16 [0.89-1.52],0.2703935245882511
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24219,46,1.07 [0.77-1.50],0.6759571518541477
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26660,2487,1.00 [0.95-1.05],0.981658311726652
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,25970,1797,1.00 [0.95-1.06],0.974350901221877
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",26937,604,1.16 [1.06-1.27],0.0013714473243797
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21341,3011,1.04 [1.00-1.09],0.0535890121125517
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18402,72,1.07 [0.82-1.40],0.6144391432685914
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23126,101,1.04 [0.83-1.31],0.7275477016408746
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18373,43,1.06 [0.75-1.50],0.7305157686040217
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18531,201,1.04 [0.88-1.22],0.6432121195608671
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24461,288,0.97 [0.85-1.11],0.6980389809238947
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,24756,583,1.02 [0.93-1.12],0.7306573075805018
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27106,112,1.07 [0.86-1.32],0.5407759045426689
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25140,2022,1.06 [1.01-1.11],0.0240573929771079
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23156,131,0.97 [0.80-1.19],0.8048954324059443
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18560,230,0.87 [0.74-1.01],0.0735745853139337
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,23932,814,1.05 [0.97-1.14],0.2150735451277887
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20845,2515,1.01 [0.97-1.06],0.5238631791649409
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26230,125,0.81 [0.66-1.00],0.0555845063183051
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27117,74,1.06 [0.82-1.37],0.6723088146370159
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23106,81,1.12 [0.88-1.43],0.3673978475004775
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24484,1459,1.08 [1.02-1.14],0.0107003956757384
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23106,81,1.36 [1.08-1.72],0.0096699809038407
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20309,1979,1.04 [0.99-1.10],0.1066982690926327
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24307,134,1.04 [0.86-1.27],0.6609191941283262
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23089,64,1.20 [0.91-1.58],0.1970479756717145
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23311,193,0.96 [0.81-1.13],0.6381370430197058
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23609,584,1.03 [0.94-1.13],0.5366455366092385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26603,498,1.09 [0.99-1.21],0.0819409898793803
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23762,644,1.04 [0.95-1.13],0.4222464968634519
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,26952,585,1.17 [1.07-1.28],0.0006419760834747
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27107,69,1.29 [1.00-1.67],0.0513403494766597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23251,226,0.93 [0.80-1.09],0.3705692626831655
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20821,901,1.08 [1.01-1.17],0.0337680898061468
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23690,665,1.06 [0.97-1.16],0.1882465208878486
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23148,123,1.09 [0.89-1.33],0.4170755889447015
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18406,76,1.03 [0.80-1.34],0.8043623222666131
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,20960,2630,1.06 [1.01-1.11],0.0122591747287502
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19164,834,1.04 [0.96-1.12],0.389861288649842
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26398,293,1.08 [0.95-1.24],0.2275486441815058
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27079,85,0.95 [0.74-1.22],0.7022692168286021
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",24859,53,0.97 [0.70-1.33],0.8359214009676844
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18404,74,1.07 [0.82-1.39],0.6302554345205118
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23231,113,1.20 [0.98-1.48],0.0837865866284115
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,18937,607,1.16 [1.06-1.27],0.0011937749317687
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23359,334,0.98 [0.86-1.11],0.7001114803179924
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23400,282,1.16 [1.02-1.32],0.0284761214831753
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23400,282,1.05 [0.92-1.20],0.4890017331260553
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,20969,87,1.20 [0.95-1.52],0.1194607673376969
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27114,76,1.15 [0.90-1.48],0.2631246379512905
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23665,640,1.02 [0.93-1.12],0.6409826801170416
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],26265,160,1.09 [0.91-1.30],0.3510518626543717
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25821,2796,1.04 [1.00-1.09],0.0695731938684007
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23182,157,0.87 [0.72-1.05],0.1463545623141375
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23697,579,1.07 [0.98-1.18],0.1393792913967473
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,25436,258,0.95 [0.82-1.09],0.4390841776667133
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23393,275,1.07 [0.94-1.23],0.3047444482691722
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24875,1757,1.03 [0.98-1.09],0.2206200321217027
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24314,1196,1.07 [1.00-1.14],0.0363346471790206
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23088,63,1.03 [0.77-1.37],0.8425328356352537
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26323,218,0.94 [0.80-1.10],0.4295215623430499
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23226,201,1.03 [0.87-1.20],0.760476699952029
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23153,128,0.94 [0.77-1.15],0.5513689355881597
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18384,54,1.35 [1.01-1.81],0.0446022577319912
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26070,1240,1.08 [1.02-1.16],0.0132666760321807
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20292,100,1.04 [0.83-1.30],0.745104334366016
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26439,112,0.98 [0.79-1.21],0.8262878073178659
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,26976,233,1.08 [0.94-1.26],0.2822240765335187
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,26770,27,0.72 [0.45-1.15],0.1710884584080356
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26307,1477,1.03 [0.97-1.09],0.398593091008222
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,26962,79,1.07 [0.83-1.38],0.6092474206098084
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,26929,242,1.12 [0.97-1.29],0.1353962978055917
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Cystitis,23944,254,1.00 [0.87-1.16],0.9549874642026948
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Dialysis,24883,53,1.20 [0.89-1.62],0.2324484286882673
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26666,339,0.96 [0.85-1.09],0.5679303010254748
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Endometriosis,20368,176,0.96 [0.80-1.14],0.6192428658678653
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20583,391,0.94 [0.84-1.06],0.3129670943694347
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21189,997,1.03 [0.95-1.10],0.4849563640018026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21121,5020,1.03 [1.00-1.06],0.0931012261872366
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,26949,66,1.15 [0.87-1.50],0.3264738939999183
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,24708,207,0.96 [0.82-1.13],0.6393285110107778
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26597,393,0.99 [0.88-1.11],0.8977832011411249
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Irregular menses,26670,126,0.87 [0.70-1.07],0.1774080644043763
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20493,301,1.01 [0.88-1.15],0.9023943828517208
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23767,77,1.04 [0.80-1.35],0.7579976894564235
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22629,2437,1.00 [0.96-1.05],0.92140879991385
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20332,140,1.08 [0.89-1.30],0.4299348055565799
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27122,65,1.08 [0.81-1.43],0.594051212448726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27126,73,0.94 [0.72-1.23],0.661378795198325
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,25906,2216,1.04 [0.99-1.09],0.1294977561570033
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24154,464,0.98 [0.89-1.10],0.7756038833966189
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26444,117,0.96 [0.78-1.19],0.7196953289045704
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27075,388,1.16 [1.04-1.30],0.0088149892344308
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27076,91,1.02 [0.80-1.29],0.8909031611971822
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25595,1905,1.04 [0.99-1.10],0.1105272572899082
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26402,198,1.02 [0.87-1.20],0.8174122389089069
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20346,154,1.08 [0.90-1.30],0.3834235206934254
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20557,365,0.98 [0.87-1.11],0.7899696574280411
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20300,108,0.97 [0.78-1.21],0.8087772746069428
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20398,206,1.06 [0.91-1.24],0.4476069486711026
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24761,260,0.98 [0.85-1.13],0.771597066532605
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,26812,125,1.19 [0.98-1.45],0.0775789490850314
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20501,309,1.00 [0.88-1.13],0.9596169072193352
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20297,105,0.95 [0.76-1.19],0.6727732246021608
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20826,634,1.03 [0.94-1.13],0.4918191748490329
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20351,159,1.10 [0.92-1.31],0.2848979950979404
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20778,586,1.07 [0.98-1.18],0.1308002672049554
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,26922,39,1.22 [0.87-1.73],0.249950101335545
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,26944,2443,1.04 [0.99-1.09],0.093888052434665
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",24661,160,1.11 [0.93-1.32],0.2450835059860944
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,24934,104,1.02 [0.81-1.27],0.8831707930556827
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26776,33,0.95 [0.64-1.42],0.7997746921930107
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23836,146,1.13 [0.94-1.36],0.1787668031458726
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27009,266,1.06 [0.92-1.22],0.4119018808740898
HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20328,136,1.17 [0.97-1.41],0.1075688791515063
